cmi_blog_daily_dose

  Oncology Radiopharmaceuticals Oncology Radiopharmaceuticals agents are designed to penetrate cancer cells and break down naturally once they attach to a cancer cell. The radioactive compound then decays, causing irreparable damage to the DNA of nearby cells. Cancer cells are particularly susceptible to DNA damage from radiation, and a single molecule of radiopharmaceutical can kill up to 10 cells around a bound cell. Radiation therapy is an important part of cancer treatment, with the National Cancer Institute estimating that nearly half of all cancer patients will receive some form of radiation therapy during their lifetimes. In radiation therapy, a beam of high-energy radiation is directed at the cancerous growth in order to kill it. Recently, however, oncologists have shown a growing interest in using radiopharmaceuticals, which are drugs that contain radioactive particles attached to them. These drugs can accurately target cancer cells and help treat cancer. Although these ...

  Targeted therapy Targeted therapy is a highly experimental and highly focused cancer treatment. Targeted therapy refers to the cancer cells that are studied and diagnosed in this treatment. Targeted therapy or molecularly targeted therapy, as it is also known is one of the main modalities of cancer treatment, the others being radiotherapy, hormonal treatment, and targeted immunotherapy. In regions such as the United States, the increasing prevalence of cancer has increased the usage of targeted therapy. For instance, according to the American Cancer Society, in 2020, there were around 1,806,590 new cancer cases in the United States. Chemotherapy or cancer treatment with Targeted Therapy uses drugs to kill cancer cells without harming healthy cells nearby. Cancer cells require specific nutrients, such as oxygen, to survive. Drugs therefore can be used to provide the nutrients to these cancer cells, and sometimes other methods are required to kill healthy cells. For instance, ce...